Alto Neuroscience, Inc.
General ticker "ANRO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $109.1M (TTM average)
Alto Neuroscience, Inc. follows the US Stock Market performance with the rate: 43.0%.
Estimated limits based on current volatility of 3.7%: low 13.60$, high 14.66$
Factors to consider:
- Total employees count: 63 as of 2023
Short-term ANRO quotes
Long-term ANRO plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $29.19MM | $37.81MM | $68.61MM |
| Operating Income | $-29.19MM | $-37.81MM | $-68.61MM |
| Non-Operating Income | $1.48MM | $1.50MM | $7.18MM |
| Interest Expense | $0.00MM | $1.37MM | $1.38MM |
| R&D Expense | $23.69MM | $30.29MM | $47.00MM |
| Income(Loss) | $-27.71MM | $-36.30MM | $-61.43MM |
| Profit(Loss)* | $-27.71MM | $-36.30MM | $-61.43MM |
| Stockholders Equity | $-38.41MM | $-71.67MM | $151.46MM |
| Assets | $50.85MM | $86.63MM | $177.54MM |
| Operating Cash Flow | $-20.39MM | $-33.45MM | $-47.42MM |
| Capital expenditure | $0.73MM | $0.47MM | $2.08MM |
| Investing Cash Flow | $-0.73MM | $-0.47MM | $-2.08MM |
| Financing Cash Flow | $43.79MM | $68.13MM | $135.69MM |
| Earnings Per Share** | $-1.08 | $-1.35 | $-2.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.